Retina and Vitreous

  • Marvin F. Kraushar
  • Peter H. Morse

Comprehensive ophthalmologists and vitreoretinal specialists must be particularly diligent when managing patients with vitreoretinal diseases. Practically every vitreoretinal diagnosis has the potential for severe visual impairment or blindness. It can be further expected that a significant number of patients will experience profound, irreversible visual loss as a result of their disease before or despite successful treatment. Our best efforts cannot prevent a percentage of the treatment we provide from being unsuccessful. The devastating visual prognosis of most of vitreoretinal diseases virtually ensures a poor visual result after failed treatment.

Patient education regarding risks during the informed consent discussion thus acquires even greater significance when managing patients with these diseases. Mention should be made of the possibility of no visual improvement or further vision loss despite successful therapy. It is of paramount importance that an optimal physician–patient relationship is established and nurtured throughout the course of treatment. This is often difficult because of the abrupt manifestation of symptoms of many vitreoretinal diseases, such as central retinal artery occlusion, retinal tear, retinal detachment, endophthalmitis, and intraocular foreign bodies, which usually require expeditious treatment the day of the first visit. In these circumstances, there is insufficient time to establish as strong a relationship as would be possible prior to an elective procedure. Patient apprehension in such situations can make comprehension of pertinent details less reliable.


Retinal Detachment Macular Hole Proliferative Diabetic Retinopathy Cystoid Macular Edema Rhegmatogenous Retinal Detachment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kraushar MF. Medical malpractice experiences of vitreoretinal specialists. Retina 2003;23:523-529.CrossRefPubMedGoogle Scholar
  2. 2.
    Sorrel AL. Failure to diagnose is the No.1 allegation in liability lawsuits. AMA News 2006;49:8-9.Google Scholar
  3. 3.
    Kraushar MF, Turner M. Medical malpractice litigation in ophthalmology: the New Jersey experience. Ophthalmic Surg 1986;17:671-674.PubMedGoogle Scholar
  4. 4.
    Bettman JW. Ophthalmology: The Art, the Law and a Little Bit of Science. New York: Aesculapius; 1977:75.Google Scholar
  5. 5.
    Kraushar MF, Robb JH. Ophthalmic malpractice lawsuits with large monetary awards. Arch Ophthalmol 1996;114:333-337.PubMedGoogle Scholar
  6. 6.
    Kraushar MF. Medical malpractice litigation in the management of vitreoretinal diseases. Arch Ophthalmol 1987;105:187-190.PubMedGoogle Scholar
  7. 7.
    Arsenault v. McConarty, 21 Mass. L. Rptr, 2006;500.Google Scholar
  8. 8.
    Alton WG. Malpractice: A trial lawyer’s advice for physicians. Boston: Little, Brown; 1977:56.Google Scholar
  9. 9.
    Holekamp NM. The ethics of Avastin. Retina Times 2006;16:32.Google Scholar
  10. 10.
    Leibovitch I, Casson R, Laforest C, Dinesh S. Ischemic orbital compartment syndrome as a complication of spinal surgery in the prone position. Ophthalmology 2006;113:105-108.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Marvin F. Kraushar
    • Peter H. Morse
      • 1
    1. 1.OphthalmologySanford School of Medicine, University of South DakotaSioux FallsUSA

    Personalised recommendations